arrow
C

Connie I. Diakos

University of Sydney
H指数:21
被引数:4,264

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial

relacorilant和nab-紫杉醇在铂耐药卵巢癌患者中的总生存期(ROSELLA):一项3期随机对照试验

2026-04-100
OAAI
Vaccine-induced immunity is maintained in glioma patients relative to other solid tumours

疫苗诱导的免疫在胶质瘤患者中维持,与其他实体瘤相比。

2025-10-150
OA
Advancing Global Health Equity in Oncology Clinical Trial Access
2024-09-240
PRE
The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer

中性粒细胞与淋巴细胞比率 (NLR),血小板与淋巴细胞比率 (PLR) 和淋巴细胞与单核细胞比率 (LMR) 作为生物标志物在切除的胰腺癌中的预后和预测作用

2023-03-0221
OAAI
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

循环肿瘤DNA指导治疗晚期非小细胞肺癌的总生存期

2022-11-1068
OA
Australasian consensus statement on the identification, prevention and management of hormonal crises in patients with neuroendocrine neoplasms (NENs) undergoing peptide receptor radionuclide therapy (PRRT)
2022-09-013
OA
Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapy

临界可切除和局部晚期胰腺癌的生存取决于新辅助治疗的持续时间和反应

EJSO
IF2.9
2021-10-0110
PREAI
Computed tomography (CT)-defined sarcopenia and myosteatosis are prevalent in patients with neuroendocrine neoplasms (NENs) treated with peptide receptor radionuclide therapy (PRRT)

在接受肽受体放射性核素治疗 (PRRT) 的神经内分泌肿瘤 (NENs) 患者中,计算机断层扫描 (CT) 定义的肌肉减少症和肌萎缩症很普遍。

2021-05-1313
PREAI